Rosiglitazone effects on blood pressure and metabolic parameters in nondipper diabetic patients

Diabetes Research and Clinical Practice

Volumn 70, Issue 1, 2005, Pages 20-25

  Negro, Roberto ^a,d   Mangieri, Tiziana ^a   Dazzi, Davide ^b   Pezzarossa, Antonio ^b   Hassan, Haslinda ^c  

^a Department of Internal Medicine   (Italy)

^b Azienda Ospedaliera Fidenza   (Italy)

^c RIPAS HOSPITAL   (Brunei Darussalam)

^d Azienda Opedaliera V Fazzi ^*  (Italy)

Author keywords

Hypertension; Insulin resistance; Rosiglitazone; Thiazolidinediones

Indexed keywords

ANTIDIABETIC AGENT; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ROSIGLITAZONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; MALE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

BLOOD GLUCOSE; BLOOD PRESSURE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; METFORMIN; MIDDLE AGED; STATISTICS, NONPARAMETRIC; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 23944499166     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2005.02.012     Document Type: Article

References (36)

1. R.A. De Fronzo, and E. Ferrannini Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease Diab. Care 14 1991 173 194
2. I.M. O'Shaughnessy, and T.A. Kotchen Epidemiologic, physiologic, and clinical implication of hypertension and insulin resistance Curr. Opin. Cardiol. 8 1993 757 764
3. L. Lind, C. Berne, and H. Lithell Prevalence of insulin resistance in essential hypertension J. Hypertens. 13 1995 1457 1462
4. D.G. Maggs, T.A. Buchanan, C.F. Burant, G. Cline, G. Gumbiner, and W.A. Hsueh Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus; a randomized, double-blind, placebo-controlled trial Ann. Int. Med. 128 1998 176 185
5. B.M. Spiegelman PPAR-γ: adipogenic regulator and thazolidinedione receptor Diabetes 47 1998 507 514
6. M. Adams, C.T. Montague, J.B. Prins, J.C. Holder, S.A. Smith, and L. Sanders Activators of peroxisome proliferator-activated receptor have depot-specific effects on human preadipocyte differentiation J. Clin. Invest. 100 1997 3149 3153
7. K.A. Virtanen, K. Hallsten, R. Parkkola, T. Janatuinen, F. Lonnqvist, and T. Viljanen Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects Diabetes 52 2003 283 290
8. A.B. Weder Sodium metabolism, hypertension and diabetes Am. J. Med. Sci. 307 1994 53 59
9. E. Ferrannini, and A. Natali Insulin resistance and hypertension: connection with sodium metabolism Review Am. J. Kidney Dis. 21 1993 37 42
10. P.C. Perin, S. Maule, and R. Quadri Sympathetic nervous system, diabetes, and hypertension Rev. Clin. Exp. Hypertens. 23 2001 45 55
11. L.M. Resnick Ionic bases of hypertension, insulin resistance, vascular disease, and related disorders - the mechanism of "Sindrome X" Am. J. Hypertens. 6 1993 123 134
12. M. Laakso, S.V. Edelman, G. Brechtel, and A.D. Baron Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM Diabetes 42 1992 1076 1083
13. T. Ogihara, H. Rakugi, H. Ikegami, and K. Masuo Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives Am. J. Hypertens. 8 1995 316 320
14. A. Uchida, T. Nakata, M. Kiyama, T. Kawa, S. Morimoto, and S. Miki Reduction of insulin resistance attenuates the development of hypertension in sucrose-fed SHR Life Sci. 61 1997 455 464
15. A. Raji, E.W. Seely, S.A. Bekins, G.H. Williams, and D.C. Simonson Rosiglitazone improves insulin sensitivity and lowers blood pressure in hypertensive patients Diab. Care 26 2003 172 178
16. S.K. Mishra, and P.I. Aaronson A role for a glibenclamide-sensitive, relatively ATP-insensitive K+ current in regulating membrane potential and current rat aorta Cardiovsc. Res. 44 1999 429 435
17. G.A. Knock, S.K. Mishra, and P.I. Aaronson Differential effects of insulin sensitizers troglitazone and rosiglitazone on ion currents in rat vascular myocytes Eur. J. Pharmacol. 368 1999 103 109
18. M. Iglarz, R.M. Touyz, F. Amiri, M.F. Lavoie, Q.N. Diep, and E.L. Schiffrin Effect of peroxisome proliferator-activated receptor-alpha and gamma on vascular remodeling in endothelin-dependent hypertension Arteriosler. Thromb. Vasc. Biol. 23 2003 45 51
19. Q.N. Diep, M. El Mabrouk, J.S. Cohn, D. Endemann, F. Amiri, and A. Virdis endothelial function, cell growth, and inflammation blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma Circulation 105 2002 2296 2302
20. U. de Faire, K. Lindvall, and B. Nilsson Noninvasive ambulatory 24 h blood pressures and basal blood pressures predict development of sustained hypertension from a borderline status Am. J. Hypertens. 6 1993 149 155
21. C.N. Cohen, F.M. Albanesi, M.F. Goncalves, and M.B. Gomes Microalbuminuria, high blood pressure burden, and nondipper phenomenon Diab. Care 24 2003 790 791
22. W.B. Kannel, R.B. D'Agostino, P.W. Wilson, A.J. Belanger, and D.R. Gagnon Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience Am. Heart J. 120 1990 672 676
23. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Teacher, and R.C. Turner Homeostasis model assessment, insulin resistance and b cell function from fasting plasma glucose and insulin concentration in humans Diabetologia 28 1985 412 419
24. T. Fujiwara, and H. Horikoshi Troglitazone and related compounds. Therapeutic potential beyond diabetes (Minireview) Life Sci. 2000 2405 2416
25. A. Lopez-Candales Metabolic syndrome X: a comprehensive review of the pathophysiology and recommended therapy J. Med. 32 2001 283 300
26. F.M. Martens, F.L. Visseren, J. Lemay, E.J. de Konong, and T.J. Rabelink Metabolic and additional vascular effects of thiazolidinediones Drugs 62 2002 1463 1480
27. F.S. Facchini, R.A. Stoohs, and G.M. Reaven Enhanced sympathetic nervous system activity. The linchpin between insulin resistance, hyperinsulinemia and heart rate Am. J. Hypertens. 9 1996 1013 1017
28. K. Watanabe, M. Sekiya, T. Tsuruoka, J. Funada, H. Kameoka, and M. Miyagawa Relationship between insulin resistance and cardiac sympathetic nervous function in essential hypertension J. Hypertens. 17 1999 1161 1168
29. G. Lembo, C. Vecchione, G. Iaccarino, and B. Trimarco The crosstalk between insulin and the sympathetic nervous system: possible implications in the pathogenesis of essential hypertension Blood Press Suppl. 1 1996 38 42
30. D.C. Shen, S.M. Shieh, M.M. Fuh, D.A. Wu, Y.D. Chen, and G.M. Reaven Resistance to insulin-stimulated-glucose uptake in patients with hypertension J. Clin. Endocrinol. Metab. 66 1988 580 583
31. J.W. Chen, S.L. Jen, W.L. Lee, N.W. Hsu, S.J. Lin, and C.T. Ting Differential glucose tolerance in dipper and nondipper essential hypertension Diab. Care 21 1998 1743 1748
32. K. Masuo, H. Mikami, T. Ogihara, and M.L. Tuck Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population Am. J. Hypertens. 10 1997 77 83
33. E. Ferrannini, G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini, and L. Graziadei Insulin resistance in essential hypertension N. Engl. J. Med. 317 1987 350 357
34. D.R. Kreiger, and L. Landsberg Mechanism in obesity-related hypertension: role of insulin and catecholamines Am. J. Hypertens. 1 1988 84 90
35. T. Ikeda, T. Gomi, N. Hirawa, J. Sakurai, and N. Yoshikawa Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity Hypertension 27 1996 1180 1186
36. P. Vollenweider, L. Tappy, D. Randin, P. Scheneiter, E. Jequier, and P. Nicod Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans J. Clin. Invest. 92 1993 147 154